2020 World Immunoprotein Testing Market for 13 Assays: Americas, EMEA, APAC—A 75-Country Analysis-Supplier Shares, Segment Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Emerging Opportunities
This new report from LeadingMarketResearch.com presents analysis of the global immunoprotein testing market in 75 countries, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.
Geographic Regions
Asia-Pacific, Europe, Latin America, Middle East, North America
Country Analyses
Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam
The report provides test volume and sales forecasts by country and market segment for the following assays:
This unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by country, market segment and individual test; reviews leading analyzers; and profiles key competitors.
Contains 475 pages and 273 tables
Geographic Regions
Asia-Pacific, Europe, Latin America, Middle East, North America
Country Analyses
Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam
The report provides test volume and sales forecasts by country and market segment for the following assays:
- C3
- C4
- Ceruloplasmin
- Free Light Chains
- Haptoglobin
- IgA
- IgE Specific
- IgE Total
- IgG
- IgM
- Immunofixation
- Prealbumin
- Protein Electrophoresis
This unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends; provides test volume and sales forecasts by country, market segment and individual test; reviews leading analyzers; and profiles key competitors.
Contains 475 pages and 273 tables
INTRODUCTION
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Ceruloplasmin
3. Free Light Chains
4. Immunofixation
5. Immunoglobulins (IgA, IgE, IgG, IgM)
6. Haptoglobin
7. Prealbumin
8. Protein Electrophoresis
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
COUNTRY ANALYSES
Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW
A. Major Immunoprotein Tests
1. Complement
a. C3
b. C4
2. Ceruloplasmin
3. Free Light Chains
4. Immunofixation
5. Immunoglobulins (IgA, IgE, IgG, IgM)
6. Haptoglobin
7. Prealbumin
8. Protein Electrophoresis
B. Instrumentation Review: Operating characteristics and features of high-, medium-, and low-volume/POC analyzers
C. Major In Vitro Diagnostic Technologies And Their Potential Applications
1. Monoclonal and Polyclonal Antibodies
2. Immunoassays
a. Technological Principle
d. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. Tandem Mass Spec
4. IT and Automation
5. Dry Chemistry
6. Biosensors
COUNTRY ANALYSES
Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Croatia, Cyprus, Czech Republic, Denmark, Egypt, Estonia, Finland, France, Germany, Ghana, Greece, Hong Kong, Hungary, Iceland, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Lithuania, Malaysia, Malta, Mexico, Morocco, Myanmar, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Peru, Philippines, Poland, Portugal, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovakia, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, UK, United Arab Emirates, USA, Venezuela, Vietnam
ALTERNATIVE MARKET PENETRATION STRATEGIES
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
1. Marketing Approaches
2. Product Complexity
3. Customer Preference
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation
POTENTIAL MARKET ENTRY BARRIERS AND RISKS
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
COMPETITIVE ASSESSMENTS
Abbott
Agilent Technologies
Beckman Coulter/Danaher
bioMerieux
Bio-Rad
DiaSorin
Eiken Chemical
Fujirebio
Grifols
Instrumentation Laboratory/Werfen
Kyowa Medex
Ortho-Clinical Diagnostics
PerkinElmer
Quest Diagnostics
Roche
Siemens Healthineers
Sysmex
Thermo Fisher
Tosoh
Wako
More Publications
2017 Global H. Pylori Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
US$ 3,915.00
March 2017
208 pages
Global Tumor Markers Testing Market, 2019-2023: Reagents and Instrumentation-Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities
US$ 27,500.00
November 2019
1200 pages
2016-2020 Germany Molecular Diagnostics and NAT Market: Supplier Shares and Sales Forecasts
US$ 1,200.00
March 2016
4 pages
Global H. Pylori Diagnostics Market, 2019-2023: Emerging Opportunities in US, Europe, Japan-Supplier Shares and Strategies, Sales Segment Forecasts, Innovative Technologies and Tests
US$ 4,350.00
June 2019
208 pages
2016-2020 World Papillomavirus Diagnostic Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
US$ 3,480.00
March 2016
196 pages